Semler Scientific® Announces Additional Bitcoin Purchases 
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
PYX-201 Phase 1 trial clinical readout on track for fall of 2024 Executive Leadership Team expanded with the appointment of...
MiNK Reports First Quarter 2024 Results
Completed $5.8 million private placement financing at 25% premium Upcoming presentation of agenT-797 in severe respiratory distress at the American...
Alimera Sciences Reports First Quarter 2024 Results
Net Revenue up 70% to $23 Million vs. Q1 2023Global End User Demand Up 23% vs. Q1 2023Reiterates Improved 2024...
Entourage Health to Hold First Quarter 2024 Financial Results Call on May 28
Financial filings are expected after the market closes on May 27, and a management conference call will follow the next...
Scorpius Holdings, Inc. Announces Pricing of Public Offering
DURHAM, N.C., May 14, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX), (“Scorpius”, or the “Company”), an integrated...
BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology
RESEARCH TRIANGLE PARK, N.C., May 14, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals Inc. (Nasdaq: BCRX) today announced that new data...
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
Potential to alleviate unmet need associated with depressed mood and anhedonia in bipolar depression; navacaprant has demonstrated the ability to...
Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024
Scope of presentation included trial design, rationale, and blinded baseline data on first 50 patients randomized into the Phase II...
Strawberry Fields REIT Announces First Quarter 2024 Operating Results
South Bend, Indiana--(Newsfile Corp. - May 14, 2024) - Strawberry Fields REIT, Inc. (NYSE American: STRW) (the "Company") reported today...
Defence Therapeutics Strengthens and Expands Global Patent Protection on Key Technologies
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or...
Biophytis Announces the Design of its Phase 2 OBA Clinical Study in Obesity
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / May 14, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the...
Dr. Amir Bajoghli and Skin & Laser Dermatology Center Introduce Pro-Nox(TM) Pain and Anxiety Management System for Enhanced Patient Comfort
MCLEAN, VA / ACCESSWIRE / May 14, 2024 / Dr. Amir Bajoghli and the Skin & Laser Dermatology Center are...
Patients for Patient Safety US Receives $100,000 to Launch ‘Project PIVOT,’ a Novel, Patient-Centered Initiative to Improve Healthcare
WASHINGTON, D.C. / ACCESSWIRE / May 13, 2024 / The Patient-Centered Outcomes Research Institute (PCORI) awarded Patients for Patient Safety...
Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...
Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
Enhancing patient care and advancing innovation with the only long-term implantable continuous glucose monitorGERMANTOWN, Md. & CHESTERFIELD, Mo.--(BUSINESS WIRE)--Senseonics Holdings,...
Akanda Corp Announces Settlement Agreement with Former CEO Tejinder Virk
London, United Kingdom--(Newsfile Corp. - May 13, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), today announced a...
DEA in Disarray: MMJ BioPharma and Other Companies Mount Legal Battle Over Marijuana, Psychedelics, and Violation of Constitutional Rights
DEA FACES FOUR FEDERAL DISTRICT COURT SUITS CLAIMING DISARRAY and CONSTITUTIONAL VIOLATIONS WASHINGTON, D.C. / ACCESSWIRE / May 13, 2024...
Ainos Reports First Quarter 2024 Financial Results
Strategic focus on VELDONA and AI-powered point-of-care testing continues during 2024US$9M growth capital secured in May strengthens financial position for...
Biolase Reports 2024 First Quarter Results; Reiterates Full-Year 2024 Guidance For Revenue Growth and Profitability
Increased Adoption of Dental Lasers and Improved Cost Structure Position Company for Sustained Long Term Growth and SuccessLAKE FOREST, CA...
Wyoming Department of Corrections and NaphCare Announce Partnership to Provide Comprehensive Healthcare Services Statewide
BIRMINGHAM, Ala. & CHEYENNE, Wyo.--(BUSINESS WIRE)--As a commitment to the safety and well-being of its inmates, the Wyoming Department of...